NCT02447887 2019-09-26Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)Fox Chase Cancer CenterPhase 1/2 Terminated3 enrolled 1 chart